A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopenia

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program2011 · 113 citations
2. 2Eltrombopag for the treatment of immune thrombocytopenia2011 · 18 citations
3. 3Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance.1987 · 403 citations
4. 4Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand2004 · 294 citations
5. 5How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment2012 · 232 citations